Latest Articles
Trending
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Editor's Pick
AI-powered platforms and search engines are synthesizing peer-reviewed medical literature into actionable insights for HCPs. What are the implications for traditional information channels? Share your perspective by taking the latest What Would You Do? poll.
Hot Topics
April’s hot topic is the ISMPP Annual Meeting, of course! Visit our Hot Topics page to get ready for the event taking place on April 19th through the 22nd in Washington, DC. See you there!
Knowledge Hub
Visit ISMPP Insider’s Knowledge Hub for content across foundational and applied themes and topics. Explore curated collections or targeted searches to view recent and archival material.
Did You Know?
The first Annual Meeting of ISMPP took place in Princeton, NJ, USA on April 25-26, 2005. At that seminal event, the initial planning for the Society and a key initiative called “Driving the Value of Publications: An Integrated Approach” were launched.
In Practice
The Dark Side of Publishing: Predatory Journals and Congresses Under Scrutiny
Predatory journals and congresses represent a significant and growing threat to the integrity of medical research, publishing, and scientific dissemination. Raising awareness across all scientific and medical communities, not just among those in publishing, is therefore crucial. This article provides practical guidance, particularly on how to identify and avoid predatory journals and congresses.
Accessibility Matters: Easy Steps to Making Healthcare Information Accessible
Healthcare information has never been more readily available than it is now. However, accessibility goes beyond mere access to information; it encompasses ensuring that all individuals—regardless of physical, sensory, or cognitive ability—can access, understand, and benefit from healthcare content. This article discusses the benefits of accessible healthcare content, current accessibility standards, common barriers, and practical tools and strategies to enhance accessibility.
Generative AI: Catalyzing Change in How Pharmaceutical Companies and Agencies Collaborate
Medical communications professionals within pharmaceutical companies and agencies are navigating the rapid acceleration of technological advances, particularly the implications and uptake of generative artificial intelligence (AI), amidst an evolving information ecosystem. This article synthesizes the transformation taking place and shares tips that catalyze collaboration as our industry, and cross-functional relationships, evolve in the age of AI.
From ISMPP
AI Policies in Medical Publications: Your Input Needed
As the use of artificial intelligence (AI) in medical communications continues to grow, many organizations are beginning to establish formal policies to guide its responsible use. To better understand current approaches and areas of need, ISMPP has launched a new member survey on company AI policies in medical publications.
Practical Strategies and Best Practices at the 2025 ISMPP Academy
ISMPP Academy was a great success leaving attendees equipped with new knowledge, practical tools, and a strengthened network to propel their careers in medical communications and publications. We look forward to the continued growth and success of ISMPP Academy in the years to come. Thank you to everyone who contributed to this remarkable event!
Publication Alert: Patients as Partners in Medical Publications: The ISMPP Journey of Engagement
ISMPP is proud to announce that an article on its journey of engagement with patients as partners in medical publications was published on September 9, 2025 in Current Medical Research and Opinion (CMRO).
What Would You Do?
When AI Shapes the Narrative: Do Pubs Teams Have a Responsibility to Act?
Your team at a sponsoring pharmaceutical company recently published a clinical study in a reputable journal. Soon after, a healthcare professional shared a summary generated by an AI-powered medical tool that appears to overstate the study’s efficacy and underrepresent key limitations. The AI summary is gaining traction in online discussions.
While the original published abstract is accurate, you recognize that its structure may make it easier for AI tools to generate simplified, and potentially misleading, interpretations. Now, there is internal debate about whether your team has any responsibility to respond. Some colleagues argue that once the manuscript is published, interpretation by third-party tools is out of the authors’ or the company’s control. Others believe there is a professional obligation to step in when summaries derived from a company-sponsored publication could influence clinical understanding. As a publications lead, you are asked how to proceed. What Would You Do?
Level of Detail for Efficacy and Safety Data in a Clinical Study Publication?
You are a medical publication professional in a pharmaceutical company, working on a clinical trial publication for a novel drug that has the potential to revolutionize the treatment of a life-threatening disease. Some of the authors are keen to emphasize the promising efficacy outcomes without, in your opinion, incorporating the same level of detail about certain adverse events. What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of ISMPP Insider that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
New! Content Lab
About Content Lab
Content Lab is ISMPP Insider’s dedicated space for timely, relevant, and practical insights in medical communications. Content Lab features concise articles designed to inform, inspire, and spark conversation among our members.
Whether you’re looking for a quick tip or a deeper dive into the challenges and opportunities facing medical publication and communication professionals,Content Lab delivers informed perspectives, straight from ISMPP. Our goal: to beyour trusted voice for advancing best practices, integrity, and innovation inmedical communications.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Knowledge Hub
Explore
ISMPP Insider’s Knowledge Hub represents a central space for exploring and discovering content, new and older. Content is organized across foundational and applied themes and topics. Explore curated collections or targeted searches to view recent and archival material.
Ethics, Integrity, & Transparency
Principles, values, and real-world considerations that guide ethical decision-making, transparency, and trust in medical publications and communications (the WHY)
Medical Writing & Communications
Practical perspectives on writing quality, collaboration, and the day-to-day practice and craft of medical communications
Standards, Guidelines, & Policies
Authoritative guidelines, policies, and evolving requirements that operationalize ethical and transparent practices and support consistent implementation (the HOW)
Innovation & Technology
Informed perspectives on emerging tools, technologies, and evolving practices shaping the future of medical communications
Publication Strategy & Planning
Strategic approaches to planning, aligning, and delivering evidence and publications across the research lifecycle
Professional Development & Community
Insights and experiences that support career growth, skills development, and engagement across the medical communications community